Tau Program News Today

There is a link between head injuries and neurological diseases, but it is clear that this Important Research could lead to a better understanding of such devastating diseases as alzheimers, parkinsons and als. This Critical Research could also benefit our veterans and troops on the ground, far too many of whom have experienced tbi and its painful lasting effects. Again, mr. Chairman, thank you for holding this hearing. With a great panel of witnesses, and i look forward to getting their insight...

StockNews.com upgraded shares of Voyager Therapeutics (NASDAQ:VYGR – Get Rating) from a buy rating to a strong-buy rating in a report published on Thursday. A number of other equities research analysts also recently weighed in on the company. Truist Financial assumed coverage on Voyager Therapeutics in a research report on Wednesday, May 10th. They set […]

StockNews.com upgraded shares of Voyager Therapeutics (NASDAQ:VYGR – Get Rating) from a buy rating to a strong-buy rating in a research report sent to investors on Thursday. Other research analysts have also issued reports about the stock. TheStreet upgraded shares of Voyager Therapeutics from a d rating to a c+ rating in a report on […]

Sutro Biopharma (NASDAQ:STRO – Get Rating) and Voyager Therapeutics (NASDAQ:VYGR – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, earnings, risk and dividends. Institutional and Insider Ownership 87.6% of Sutro Biopharma shares […]

Voyager Therapeutics (NASDAQ:VYGR – Get Rating) and Sutro Biopharma (NASDAQ:STRO – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Risk & Volatility Voyager Therapeutics has a beta of […]

Truist Financial began coverage on shares of Voyager Therapeutics (NASDAQ:VYGR – Get Rating) in a research note published on Wednesday morning, The Fly reports. The firm issued a buy rating and a $18.00 target price on the stock. VYGR has been the subject of several other research reports. StockNews.com cut shares of Voyager Therapeutics from […]

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Rating) – Analysts at Wedbush issued their Q1 2024 earnings per share estimates for Voyager Therapeutics in a research report issued on Tuesday, May 9th. Wedbush analyst L. Chico forecasts that the company will post earnings per share of ($0.67) for the quarter. The consensus estimate for Voyager Therapeutics’ […]

StockNews.com upgraded shares of Voyager Therapeutics (NASDAQ:VYGR – Get Rating) from a hold rating to a buy rating in a research report sent to investors on Thursday. Other analysts have also issued research reports about the stock. Truist Financial assumed coverage on shares of Voyager Therapeutics in a research note on Wednesday. They set a […]

C4 Therapeutics (NASDAQ:CCCC – Get Rating) and Voyager Therapeutics (NASDAQ:VYGR – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations. Institutional and Insider Ownership 80.3% of C4 Therapeutics shares […]

C4 Therapeutics (NASDAQ:CCCC – Get Rating) and Voyager Therapeutics (NASDAQ:VYGR – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends. Earnings & Valuation This table compares C4 Therapeutics and […]